STUDY: Resistance to anti-EGFR therapy in colorectal cancer

Study Description

Monoclonal antibodies targeting the Epidermal Growth Factor Receptor (EGFR), such as cetuximab and panitumumab, have evolved to important... Show More

Study Accession Alternative Stable ID type
EGAS00001000582 Other

Publications